| Ytd | -47.60% | |
| 1y | -41.04% |
| Open | 9.33 | Prev Close | 9.23 | Low | 9.33 | High | 9.56 | Mkt Cap | 95.16M |
| Vol | 22.15K | Avg Vol | 53.79K | EPS | -1.30 | P/E | N/A | Forward P/E | -1.52 |
| Beta | 0.49 | Short Ratio | 7.11 | Inst. Own | 50.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 9.09 | 200-d Avg | 8.13 | 1yr Est | 16.33 |
ATRA News
[url="]Atara Biotherapeutics, Inc.[/url] (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveragin
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel a
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-ce
Yarrow Bioscience (NASDAQ: YARW - Get Free Report) and Atara Biotherapeutics (NASDAQ: ATRA - Get Fre
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market s
Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.32) per share which met the ana
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-ce
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-ce
CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused
NEW YORK, May 26, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholder
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors abou
LOS ANGELES, May 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors
New York, New York--(Newsfile Corp. - May 22, 2026) - Bronstein, Gewirtz & Grossman, LLC, a national
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, r
NEW YORK--(BUSINESS WIRE)---- $ATRA #ATRA--Faruqi & Faruqi, LLP, a leading national securities law f
New York, New York--(Newsfile Corp. - May 21, 2026) - WHY: Rosen Law Firm, a global investor rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been
NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogniz
Atara stock soars 82% as the FDA outlines a regulatory pathway for its lead product candidate, tab-c
LOS ANGELES, May 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights li
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.29) per share which beat the an
https://www.sec.gov/Archives/edgar/data/1604464/000119312526219518/atra-424-b5-2026_q2.htm
Canaccord Genuity analyst John Newman upgrades Atara Biotherapeutics (NASDAQ:ATRA) from Hold to B
Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel al
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after repor
Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea
During Wednesday's session, 212 companies made new 52-week lows.
During Tuesday's morning session, 137 companies made new 52-week lows.
On Thursday, 221 companies hit new 52-week lows.
On Wednesday, 129 stocks made new 52-week lows.
On Tuesday, 166 companies set new 52-week lows.
On Friday, 199 companies reached new 52-week lows.